Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Molecular Diagnostics and NAT Market Size Growth Rate by Type (2014-2025) 1.4.2 Amplification Technologies 1.4.3 Amplified Gene Detection Technologies 1.4.4 DNA And Oligonucleotide Microarrays 1.4.5 Gene Sequencing 1.5 Market by Application 1.5.1 Global Molecular Diagnostics and NAT Market Share by Application (2014-2025) 1.5.2 Hospitals and Clinics 1.5.3 Research Institutes 1.5.4 Diagnostic Centers 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Molecular Diagnostics and NAT Market Size 2.2 Molecular Diagnostics and NAT Growth Trends by Regions 2.2.1 Molecular Diagnostics and NAT Market Size by Regions (2014-2025) 2.2.2 Molecular Diagnostics and NAT Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Molecular Diagnostics and NAT Market Size by Manufacturers 3.1.1 Global Molecular Diagnostics and NAT Revenue by Manufacturers (2014-2019) 3.1.2 Global Molecular Diagnostics and NAT Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Molecular Diagnostics and NAT Market Concentration Ratio (CR5 and HHI) 3.2 Molecular Diagnostics and NAT Key Players Head office and Area Served 3.3 Key Players Molecular Diagnostics and NAT Product/Solution/Service 3.4 Date of Enter into Molecular Diagnostics and NAT Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Molecular Diagnostics and NAT Market Size by Type (2014-2019) 4.2 Global Molecular Diagnostics and NAT Market Size by Application (2014-2019) 5 United States 5.1 United States Molecular Diagnostics and NAT Market Size (2014-2019) 5.2 Molecular Diagnostics and NAT Key Players in United States 5.3 United States Molecular Diagnostics and NAT Market Size by Type 5.4 United States Molecular Diagnostics and NAT Market Size by Application 6 Europe 6.1 Europe Molecular Diagnostics and NAT Market Size (2014-2019) 6.2 Molecular Diagnostics and NAT Key Players in Europe 6.3 Europe Molecular Diagnostics and NAT Market Size by Type 6.4 Europe Molecular Diagnostics and NAT Market Size by Application 7 China 7.1 China Molecular Diagnostics and NAT Market Size (2014-2019) 7.2 Molecular Diagnostics and NAT Key Players in China 7.3 China Molecular Diagnostics and NAT Market Size by Type 7.4 China Molecular Diagnostics and NAT Market Size by Application 8 Japan 8.1 Japan Molecular Diagnostics and NAT Market Size (2014-2019) 8.2 Molecular Diagnostics and NAT Key Players in Japan 8.3 Japan Molecular Diagnostics and NAT Market Size by Type 8.4 Japan Molecular Diagnostics and NAT Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Molecular Diagnostics and NAT Market Size (2014-2019) 9.2 Molecular Diagnostics and NAT Key Players in Southeast Asia 9.3 Southeast Asia Molecular Diagnostics and NAT Market Size by Type 9.4 Southeast Asia Molecular Diagnostics and NAT Market Size by Application 10 India 10.1 India Molecular Diagnostics and NAT Market Size (2014-2019) 10.2 Molecular Diagnostics and NAT Key Players in India 10.3 India Molecular Diagnostics and NAT Market Size by Type 10.4 India Molecular Diagnostics and NAT Market Size by Application 11 Central & South America 11.1 Central & South America Molecular Diagnostics and NAT Market Size (2014-2019) 11.2 Molecular Diagnostics and NAT Key Players in Central & South America 11.3 Central & South America Molecular Diagnostics and NAT Market Size by Type 11.4 Central & South America Molecular Diagnostics and NAT Market Size by Application 12 International Players Profiles 12.1 Roche 12.1.1 Roche Company Details 12.1.2 Company Description and Business Overview 12.1.3 Molecular Diagnostics and NAT Introduction 12.1.4 Roche Revenue in Molecular Diagnostics and NAT Business (2014-2019) 12.1.5 Roche Recent Development 12.2 Abbott 12.2.1 Abbott Company Details 12.2.2 Company Description and Business Overview 12.2.3 Molecular Diagnostics and NAT Introduction 12.2.4 Abbott Revenue in Molecular Diagnostics and NAT Business (2014-2019) 12.2.5 Abbott Recent Development 12.3 BD 12.3.1 BD Company Details 12.3.2 Company Description and Business Overview 12.3.3 Molecular Diagnostics and NAT Introduction 12.3.4 BD Revenue in Molecular Diagnostics and NAT Business (2014-2019) 12.3.5 BD Recent Development 12.4 Biomerieux 12.4.1 Biomerieux Company Details 12.4.2 Company Description and Business Overview 12.4.3 Molecular Diagnostics and NAT Introduction 12.4.4 Biomerieux Revenue in Molecular Diagnostics and NAT Business (2014-2019) 12.4.5 Biomerieux Recent Development 12.5 Qiagen 12.5.1 Qiagen Company Details 12.5.2 Company Description and Business Overview 12.5.3 Molecular Diagnostics and NAT Introduction 12.5.4 Qiagen Revenue in Molecular Diagnostics and NAT Business (2014-2019) 12.5.5 Qiagen Recent Development 12.6 Thermo Fisher Scientific 12.6.1 Thermo Fisher Scientific Company Details 12.6.2 Company Description and Business Overview 12.6.3 Molecular Diagnostics and NAT Introduction 12.6.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics and NAT Business (2014-2019) 12.6.5 Thermo Fisher Scientific Recent Development 12.7 Agilent 12.7.1 Agilent Company Details 12.7.2 Company Description and Business Overview 12.7.3 Molecular Diagnostics and NAT Introduction 12.7.4 Agilent Revenue in Molecular Diagnostics and NAT Business (2014-2019) 12.7.5 Agilent Recent Development 12.8 GenMark 12.8.1 GenMark Company Details 12.8.2 Company Description and Business Overview 12.8.3 Molecular Diagnostics and NAT Introduction 12.8.4 GenMark Revenue in Molecular Diagnostics and NAT Business (2014-2019) 12.8.5 GenMark Recent Development 12.9 Siemens Healthcare 12.9.1 Siemens Healthcare Company Details 12.9.2 Company Description and Business Overview 12.9.3 Molecular Diagnostics and NAT Introduction 12.9.4 Siemens Healthcare Revenue in Molecular Diagnostics and NAT Business (2014-2019) 12.9.5 Siemens Healthcare Recent Development 12.10 AutoGenomics 12.10.1 AutoGenomics Company Details 12.10.2 Company Description and Business Overview 12.10.3 Molecular Diagnostics and NAT Introduction 12.10.4 AutoGenomics Revenue in Molecular Diagnostics and NAT Business (2014-2019) 12.10.5 AutoGenomics Recent Development 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Molecular Diagnostics and NAT Key Market Segments Table Key Players Molecular Diagnostics and NAT Covered Table Global Molecular Diagnostics and NAT Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Molecular Diagnostics and NAT Market Size Market Share by Type 2014-2025 Figure Amplification Technologies Figures Table Key Players of Amplification Technologies Figure Amplified Gene Detection Technologies Figures Table Key Players of Amplified Gene Detection Technologies Figure DNA And Oligonucleotide Microarrays Figures Table Key Players of DNA And Oligonucleotide Microarrays Figure Gene Sequencing Figures Table Key Players of Gene Sequencing Table Global Molecular Diagnostics and NAT Market Size Growth by Application 2014-2025 (Million US$) Figure Hospitals and Clinics Case Studies Figure Research Institutes Case Studies Figure Diagnostic Centers Case Studies Figure Molecular Diagnostics and NAT Report Years Considered Table Global Molecular Diagnostics and NAT Market Size 2014-2025 (Million US$) Figure Global Molecular Diagnostics and NAT Market Size and Growth Rate 2014-2025 (Million US$) Table Global Molecular Diagnostics and NAT Market Size by Regions 2014-2025 (Million US$) Table Global Molecular Diagnostics and NAT Market Size by Regions 2014-2019 (Million US$) Table Global Molecular Diagnostics and NAT Market Share by Regions 2014-2019 Figure Global Molecular Diagnostics and NAT Market Share by Regions 2014-2019 Figure Global Molecular Diagnostics and NAT Market Share by Regions 2019 Table Market Top Trends Table Global Molecular Diagnostics and NAT Revenue by Manufacturers (2014-2019) (Million US$) Table Global Molecular Diagnostics and NAT Market Share by Manufacturers (2014-2019) Figure Global Molecular Diagnostics and NAT Market Share by Manufacturers in 2018 Table Global Molecular Diagnostics and NAT Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Molecular Diagnostics and NAT Product/Solution/Service Table Date of Enter into Molecular Diagnostics and NAT Market Table Mergers & Acquisitions, Expansion Plans Table Global Molecular Diagnostics and NAT Market Size by Type (2014-2019) (Million US$) Table Global Molecular Diagnostics and NAT Market Size Share by Type (2014-2019) Figure Global Molecular Diagnostics and NAT Market Size Market Share by Type (2014-2019) Table Global Molecular Diagnostics and NAT Market Size by Application (2014-2019) (Million US$) Table Global Molecular Diagnostics and NAT Market Size Share by Application (2014-2019) Figure Global Molecular Diagnostics and NAT Market Size Market Share by Application (2014-2019) Figure Global Molecular Diagnostics and NAT Revenue Market Share by Application in 2018 Figure United States Molecular Diagnostics and NAT Market Size 2014-2019 (Million US$) Table United States Key Players Molecular Diagnostics and NAT Revenue (2018-2019) (Million US$) Table United States Key Players Molecular Diagnostics and NAT Market Share (2018-2019) Table United States Molecular Diagnostics and NAT Market Size by Type (2014-2019) (Million US$) Table United States Molecular Diagnostics and NAT Market Share by Type (2014-2019) Table United States Molecular Diagnostics and NAT Market Size by Application (2014-2019) (Million US$) Table United States Molecular Diagnostics and NAT Market Share by Application (2014-2019) Figure Europe Molecular Diagnostics and NAT Market Size 2014-2019 (Million US$) Table Europe Key Players Molecular Diagnostics and NAT Revenue (2018-2019) (Million US$) Table Europe Key Players Molecular Diagnostics and NAT Market Share (2018-2019) Table Europe Molecular Diagnostics and NAT Market Size by Type (2014-2019) (Million US$) Table Europe Molecular Diagnostics and NAT Market Share by Type (2014-2019) Table Europe Molecular Diagnostics and NAT Market Size by Application (2014-2019) (Million US$) Table Europe Molecular Diagnostics and NAT Market Share by Application (2014-2019) Figure China Molecular Diagnostics and NAT Market Size 2014-2019 (Million US$) Table China Key Players Molecular Diagnostics and NAT Revenue (2018-2019) (Million US$) Table China Key Players Molecular Diagnostics and NAT Market Share (2018-2019) Table China Molecular Diagnostics and NAT Market Size by Type (2014-20189) (Million US$) Table China Molecular Diagnostics and NAT Market Share by Type (2014-2019) Table China Molecular Diagnostics and NAT Market Size by Application (2014-2019) (Million US$) Table China Molecular Diagnostics and NAT Market Share by Application (2014-2019) Figure Japan Molecular Diagnostics and NAT Market Size 2014-2019 (Million US$) Table Japan Key Players Molecular Diagnostics and NAT Revenue (2018-2019) (Million US$) Table Japan Key Players Molecular Diagnostics and NAT Market Share (2018-2019) Table Japan Molecular Diagnostics and NAT Market Size by Type (2014-2019) (Million US$) Table Japan Molecular Diagnostics and NAT Market Share by Type (2014-2019) Table Japan Molecular Diagnostics and NAT Market Size by Application (2014-2019) (Million US$) Table Japan Molecular Diagnostics and NAT Market Share by Application (2014-2019) Figure Southeast Asia Molecular Diagnostics and NAT Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Molecular Diagnostics and NAT Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Molecular Diagnostics and NAT Market Share (2018-2019) Table Southeast Asia Molecular Diagnostics and NAT Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Molecular Diagnostics and NAT Market Share by Type (2014-2019) Table Southeast Asia Molecular Diagnostics and NAT Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Molecular Diagnostics and NAT Market Share by Application (2014-2019) Figure India Molecular Diagnostics and NAT Market Size 2014-2019 (Million US$) Table India Key Players Molecular Diagnostics and NAT Revenue (2018-2019) (Million US$) Table India Key Players Molecular Diagnostics and NAT Market Share (2018-2019) Table India Molecular Diagnostics and NAT Market Size by Type (2014-2019) (Million US$) Table India Molecular Diagnostics and NAT Market Share by Type (2014-2019) Table India Molecular Diagnostics and NAT Market Size by Application (2014-2019) (Million US$) Table India Molecular Diagnostics and NAT Market Share by Application (2014-2019) Figure Central & South America Molecular Diagnostics and NAT Market Size 2014-2019 (Million US$) Table Central & South America Key Players Molecular Diagnostics and NAT Revenue (2018-2019) (Million US$) Table Central & South America Key Players Molecular Diagnostics and NAT Market Share (2018-2019) Table Central & South America Molecular Diagnostics and NAT Market Size by Type (2014-2019) (Million US$) Table Central & South America Molecular Diagnostics and NAT Market Share by Type (2014-2019) Table Central & South America Molecular Diagnostics and NAT Market Size by Application (2014-2019) (Million US$) Table Central & South America Molecular Diagnostics and NAT Market Share by Application (2014-2019) Table Roche Company Details Table Roche Revenue in Molecular Diagnostics and NAT Business (2014-2019) (Million US$) Figure Roche Revenue Growth Rate in Molecular Diagnostics and NAT Business (2014-2019) Table Roche Recent Development Table Abbott Company Details Table Abbott Revenue in Molecular Diagnostics and NAT Business (2014-2019)(Million US$) Figure Abbott Revenue Growth Rate in Molecular Diagnostics and NAT Business (2014-2019) Table Abbott Recent Development Table BD Company Details Table BD Revenue in Molecular Diagnostics and NAT Business (2014-2019)(Million US$) Figure BD Revenue Growth Rate in Molecular Diagnostics and NAT Business (2014-2019) Table BD Recent Development Table Biomerieux Company Details Table Biomerieux Revenue in Molecular Diagnostics and NAT Business (2014-2019)(Million US$) Figure Biomerieux Revenue Growth Rate in Molecular Diagnostics and NAT Business (2014-2019) Table Biomerieux Recent Development Table Qiagen Company Details Table Qiagen Revenue in Molecular Diagnostics and NAT Business (2014-2019)(Million US$) Figure Qiagen Revenue Growth Rate in Molecular Diagnostics and NAT Business (2014-2019) Table Qiagen Recent Development Table Thermo Fisher Scientific Company Details Table Thermo Fisher Scientific Revenue in Molecular Diagnostics and NAT Business (2014-2019)(Million US$) Figure Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnostics and NAT Business (2014-2019) Table Thermo Fisher Scientific Recent Development Table Agilent Company Details Table Agilent Revenue in Molecular Diagnostics and NAT Business (2014-2019)(Million US$) Figure Agilent Revenue Growth Rate in Molecular Diagnostics and NAT Business (2014-2019) Table Agilent Recent Development Table GenMark Company Details Table GenMark Revenue in Molecular Diagnostics and NAT Business (2014-2019)(Million US$) Figure GenMark Revenue Growth Rate in Molecular Diagnostics and NAT Business (2014-2019) Table GenMark Recent Development Table Siemens Healthcare Company Details Table Siemens Healthcare Revenue in Molecular Diagnostics and NAT Business (2014-2019)(Million US$) Figure Siemens Healthcare Revenue Growth Rate in Molecular Diagnostics and NAT Business (2014-2019) Table Siemens Healthcare Recent Development Table AutoGenomics Company Details Table AutoGenomics Revenue in Molecular Diagnostics and NAT Business (2014-2019)(Million US$) Figure AutoGenomics Revenue Growth Rate in Molecular Diagnostics and NAT Business (2014-2019) Table AutoGenomics Recent Development Table Global Molecular Diagnostics and NAT Market Size by Regions (Million US$) 2019-2025 Figure Global Molecular Diagnostics and NAT Market Size Share by Regions (2019-2025) Figure Global Molecular Diagnostics and NAT Market Size Share by Regions in 2025 Figure United States Molecular Diagnostics and NAT Market Size Forecast (2019-2025)(Million USD) Figure Europe Molecular Diagnostics and NAT Market Size Forecast (2019-2025)(Million USD) Figure China Molecular Diagnostics and NAT Market Size Forecast (2019-2025)(Million USD) Figure Japan Molecular Diagnostics and NAT Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Molecular Diagnostics and NAT Market Size Forecast (2019-2025)(Million USD) Figure India Molecular Diagnostics and NAT Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Molecular Diagnostics and NAT Market Size Forecast (2019-2025)(Million USD) Table Global Molecular Diagnostics and NAT Market Size by Product (2019-2025) (Million US$) Figure Global Molecular Diagnostics and NAT Market Size by Product (2019-2025) Figure Global Molecular Diagnostics and NAT Market Size by Product in 2025 Table Global Molecular Diagnostics and NAT Market Size by Application (2019-2025) (Million US$) Figure Global Molecular Diagnostics and NAT Market Size by Application (2019-2025) Figure Global Molecular Diagnostics and NAT Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Roche Abbott BD Biomerieux Qiagen Thermo Fisher Scientific Agilent GenMark Siemens Healthcare AutoGenomics